Acquired
Novo Nordisk (Ozempic)
David Rosenthal
And by the end of the 1980s, Nordisk is now up to 20% global market share in insulin. And that's really all come at the expense of Novo, which is down to 30% global market share. Whoa, so they're close to matching them. Yeah, they're pretty close. And this brings us finally...
0
💬
0
Comments
Log in to comment.
There are no comments yet.